Mesothelioma Most mesotheliomas originate in the pleura and are due to asbestos
exposure. The incidence is decreasing somewhat with asbestos remediation, but mortality …

Malignant pleural effusions (MPE) are a common pathology, treated by respiratory
physicians and thoracic surgeons alike. In recent years, several well-designed randomized …

Incomplete and inadequate reporting is an avoidable waste that reduces the usefulness of
research. The CONSORT (Consolidated Standards of Reporting Trials) Statement is an …

Incidence of malignant pleural mesothelioma (MPM) is generally higher in males than
females and is attributed to historical differences in exposures with world-standardised …

Purpose To provide evidence-based recommendations to practicing physicians and others
on the management of malignant pleural mesothelioma. Methods ASCO convened an …

The European Respiratory Society (ERS)/European Society of Thoracic Surgeons
(ESTS)/European Association for Cardio-Thoracic Surgery (EACTS)/European Society for …

Malignant pleural mesothelioma is an aggressive malignancy of the pleural surface,
predominantly caused by prior asbestos exposure. There is a global epidemic of malignant …

Malignant pleural mesothelioma (MPM) is considered to be a relatively rare tumour. In Great
Britain, the incidence in males is 3.4/100 000, in France it is 2.3/100 000 and in the …

Refer all patients with a chest X-ray suggestive of MPM urgently (via the 2-week wait
suspected cancer pathway in England and Wales). Consider referral for further investigation …

Background Malignant pleural effusion (MPE) is a common problem for people with cancer
as a result of malignant infiltration of the pleura. It is usually associated with considerable …